EUVIMEDEUVIMED entdecken
Crossref

Glucosyltriazole amphiphile treatment attenuates breast cancer by modulating the AMPK signaling

Neeraj Kumar Chouhan, Abhisheik Eedara, Mamta N Talati, Sudha S S S S Ambadipudi, Sai Balaji Andugulapati iD, Srihari Pabbaraja iD

Drug Development Research · 2024

DOI: 10.1002/ddr.22215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Neeraj Kumar Chouhan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, India. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Antineoplastic Agents, Apoptosis, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the second most frequent cancer among women. Out of various subtypes, triple‐negative breast cancers (TNBCs) account for 15% of breast cancers and exhibit more aggressive characteristics as well as a worse prognosis due to their proclivity for metastatic progression and limited therapeutic strategies. It has been demonstrated that AMP‐activated protein kinase (AMPK) has context‐specific protumorigenic implications in breast cancer cells. A set of glucosyltriazole amphiphiles, consisting of acetylated ( 9a‐h ) and unmodified sugar hydroxyl groups ( 10a‐h ), were synthesized and subjected to in vitro biological evaluation. Among them, 9h exhibited significant anticancer activity against MDA‐MB‐231, MCF‐7, and 4T1 cell lines with IC 50 values of 12.5, 15, and 12.55 μM, respectively. Further, compound 9h was evaluated for apoptosis and cell cycle analysis in in vitro models (using breast cancer cells) and antitumour activity in an in vivo model (orthotopic mouse model using 4T1 cells). Annexin‐V assay results revealed that treatment with 9h caused 34% and 28% cell death at a concentration of 15 or 7.5 μM, respectively, while cell cycle analysis demonstrated that 9h arrested the cells at the G2/M or G1 phase in MCF‐7, MDA‐MB‐231 and 4T1 cells, respectively. Further, in vivo, investigation showed that compound 9h exhibited equipotent as doxorubicin at 7.5 mg/kg, and superior efficacy than doxorubicin at 15 mg/kg. The mechanistic approach revealed that 9h showed potent anticancer activity in an in vivo orthotopic model (4T1 cells) partly by suppressing the AMPK activation. Therefore, modulating the AMPK activation could be a probable approach for targeting breast cancer and mitigating cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesAntineoplastic AgentsApoptosisSignal TransductionTriazolesAnimalsFemaleHumansMiceBreast NeoplasmsCell Line, TumorCell ProliferationMCF-7 CellsMice, Inbred BALB CXenograft Model Antitumor Assays

Stichwörter der Autor:innen

AMPKclick chemistryglucosyltriazole amphiphiles (GTAs)glycolipidstriple‐negative breast cancer (TNBC)

Substanzen

AMP-Activated Protein KinasesAntineoplastic AgentsTriazoles

Autor:innen und Institutionen

  • Department of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India.

ORCID-Profile: Sai Balaji Andugulapati, Srihari Pabbaraja

Zitieren

APA

Chouhan, N. K., Eedara, A., Talati, M. N., Ambadipudi, S. S. S. S. S., Andugulapati, S. B., & Pabbaraja, S. (2024). Glucosyltriazole amphiphile treatment attenuates breast cancer by modulating the AMPK signaling. Drug Development Research. https://doi.org/10.1002/ddr.22215

Vancouver

Chouhan NK, Eedara A, Talati MN, Ambadipudi SSSSS, Andugulapati SB, Pabbaraja S. Glucosyltriazole amphiphile treatment attenuates breast cancer by modulating the AMPK signaling. Drug Development Research. 2024. doi:10.1002/ddr.22215

BibTeX
@article{Chouhan2024,
  author = {Chouhan, Neeraj Kumar and Eedara, Abhisheik and Talati, Mamta N and Ambadipudi, Sudha S S S S and Andugulapati, Sai Balaji and Pabbaraja, Srihari},
  title = {Glucosyltriazole amphiphile treatment attenuates breast cancer by modulating the AMPK signaling},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22215}
}
Kostenlos starten →